semaglutide compounding ban 🚨 FDA Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale of GLP-1 medications like and tirzepatide, signaling a major shift in how these Pharma's mess of its own

State-licensed pharmacies compound under Section 503A of the Federal Food, Drug, and Cosmetic Act, while FDA-registered outsourcing facilities operate under Section 503B

Thats reassuring because many women need both

We publish educational articles, research summaries, protocol overviews, and safety considerations so you can understand what the evidence supports before you decide what questions to bring to a clinician or what claims to discard

If not, are you planning on using any

On efficacy, a 12-week randomized controlled trial (approximately 300 obese adults) showed subjects receiving 1 mg/day of AOD-9604 lost an average of 2.6 kg , versus 0.8 kg in the placebo group